161 related articles for article (PubMed ID: 471320)
1. [Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation].
Buzio C; Dall'Aglio PP; Delmonte G; Montagna G; Migone L
Minerva Nefrol; 1979; 26(1):45-8. PubMed ID: 471320
[No Abstract] [Full Text] [Related]
2. Separation, isolation and amino acid composition of uremic peptides.
Shaykh M; Dubin A; Dunea G; Mamdani B; Ahmed S
Clin Physiol Biochem; 1984; 2(1):1-13. PubMed ID: 6488692
[TBL] [Abstract][Full Text] [Related]
3. Uremic middle molecules exist and are biologically active.
Bergström J; Fürst P; Zimmerman L
Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
[No Abstract] [Full Text] [Related]
4. Technical aspects on middle molecules: separation, isolation, and identification.
Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
[TBL] [Abstract][Full Text] [Related]
5. ["Middle molecules" as nonspecific regulators of phagocyte activity].
Volchegorskiĭ IA; Vlasov AV; Livshits GE; Akhkiamov EM; Skobeleva NA; Lifshits RI; Ebert LIa
Biull Eksp Biol Med; 1995 Feb; 119(2):159-62. PubMed ID: 7670039
[No Abstract] [Full Text] [Related]
6. [Influence of aging and obesity on serum levels of free amino acids and other ninhydrin-positive substances in man].
Takayama H; Aoyama A; Tomiyama M; Minagawa A; Yano T; Shibuya M; Shimabukuro Z; Sakai S
Nihon Ronen Igakkai Zasshi; 1982 Sep; 19(5):487-500. PubMed ID: 7154383
[No Abstract] [Full Text] [Related]
7. Uremic toxins and the elusive middle molecules.
Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
[No Abstract] [Full Text] [Related]
8. The synthesis of middle molecular substances in rat tissues: in vitro study.
Dzúrik R; Cernácek P; Spustová V; Válek A
Proc Eur Dial Transplant Assoc; 1978; 15():633-5. PubMed ID: 740703
[No Abstract] [Full Text] [Related]
9. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
Li G; Chu J; Liu X; Yuan Z
Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
[TBL] [Abstract][Full Text] [Related]
10. Methodology for identification of serum middle molecules.
Buzio C; Montagna G; Calderini C; Manari A; Migone L
Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
[TBL] [Abstract][Full Text] [Related]
11. In vivo accumulation of sodium pump inhibitor by normal and uremic erythrocytes.
Gallice P; Lai E; Brunet P; Berland Y; Elsen R; Crevat A
Int J Artif Organs; 1993 Mar; 16(3):120-2. PubMed ID: 8390969
[TBL] [Abstract][Full Text] [Related]
12. Determination of endogenous middle molecules in normal and uremic body fluids.
Fürst P; Zimmerman L; Bergström J
Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
[TBL] [Abstract][Full Text] [Related]
13. Chemical analytic approaches to the definition of uremic toxins.
Furst P; Bergstrom J; Gordon A; Zimmermann L
Ateneo Parmense Acta Biomed; 1975; 46(5):307-16. PubMed ID: 1232992
[TBL] [Abstract][Full Text] [Related]
14. Serum middle molecules in uremia.
Buzio C; Manari A; Calderini C; Montagna G; Migone L
Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
[No Abstract] [Full Text] [Related]
15. [Free amino acids and ninhydrin-positive substances in human prostatic tissue].
Van Camp K; van Sande M
Verh K Acad Geneeskd Belg; 1980; 42(2):105-34. PubMed ID: 6164177
[No Abstract] [Full Text] [Related]
16. Plasma middle molecules in asymptomatic and "sick" uremic patients.
Asaba H; Bergström J; Fürst P; Johnson C; Yahiel V
Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080
[TBL] [Abstract][Full Text] [Related]
17. Uremic neurotoxin in the middle molecular weight range.
Man NK; Cueille G; Zingraff J; Boudet J; Sausse A; Funck-Brentano JL
Artif Organs; 1980 May; 4(2):116-20. PubMed ID: 7396764
[TBL] [Abstract][Full Text] [Related]
18. Uremic middle molecules in non-dialyzed azotemic patients: relation to symptoms and clinical biochemistries.
Asaba H; Alvestrand A; Bergström J; Fürst P; Yahiel V
Clin Nephrol; 1982 Feb; 17(2):90-5. PubMed ID: 7067171
[TBL] [Abstract][Full Text] [Related]
19. [Study of toxic activity of blood in uremia].
Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
[No Abstract] [Full Text] [Related]
20. Many hitherto unknown peptides are principal constituents of uremic "middle molecules".
Menyhárt J; Gróf J
Clin Chem; 1981 Oct; 27(10):1712-6. PubMed ID: 7285323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
